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Summary
AIMS OF THE STUDY: Vaccination is regarded as the
most promising response to the COVID-19 pandemic. We
assessed opinions about COVID-19 vaccination, willing-
ness to be vaccinated, and reasons for vaccination hesi-
tancy among healthcare workers.
METHODS: We conducted a cross-sectional, web-based
survey among 3,793 healthcare workers in December
2020 in the Canton of Solothurn, Switzerland, before the
start of the national COVID-19 vaccination campaign.
RESULTS: Median age was 43 years (interquartile range
[IQR] 31–53), 2,841 were female (74.9%). A total of 1,511
healthcare workers (39.8%) reported willingness to accept
vaccination, whereas 1,114 (29.4%) were unsure and
1,168 (30.8%) would decline vaccination. Among medical
doctors, 76.1% were willing, whereas only 27.8% of nurs-
es expressed willingness. Among the 1,168 healthcare
workers who would decline vaccination, 1,073 (91.9%) ex-
pressed concerns about vaccine safety and side effects.
The willingness of healthcare workers to be vaccinated
was associated with older age (adjusted odds ratio [aOR]
1.97, 95% confidence interval [Cl] 1.71–2.27) and having
been vaccinated for influenza this year (aOR 2.70, 95%
Cl 2.20–3.31). Healthcare workers who reported a lack of
confidence in government were less likely to be willing to
be vaccinated (aOR 0.58, 95% Cl 0.40–0.84), and women
were less willing to be vaccinated than men (OR 0.33,
95% CI 0.28–0.38).
CONCLUSION: Less than half of healthcare workers re-
ported willingness to be vaccinated before the campaign
start, but proportions varied greatly depending on profes-
sion and workplace. Strategies with clear and objective
messages that particularly address the concerns of health-
care workers are needed if their willingness to be vacci-
nated against COVID-19 is to be further increased.
Introduction
The worldwide spread of severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) infections and coron-
avirus disease 2019 (COVID-19) is a major public health
threat [1]. Globally, SARS-CoV-2 infection has been con-
firmed in over 131,837,512 people and as of 7 April 2021
2,862,664 have died from COVID-19 [2]. In Switzerland,
the pandemic has stretched the healthcare system to its lim-
its and burdened the economy with temporary closures of
restaurants, stores and large public and private venues [4].
In the absence of effective treatments and a safe and effec-
tive vaccine, nonpharmaceutical interventions were imple-
mented to mitigate the pandemic. Measures taken include
using personal protective equipment (PPE) such as face
masks in public spaces, keeping distance between indi-
viduals, and rigorous hand hygiene. Many pharmaceutical
companies and research laboratories have been working on
vaccines [5–7]. Effective vaccination is key to controlling
the COVID-19 pandemic, but global vaccine distribution
is challenging [8]. By the end of 2020, several vaccines
had demonstrated efficacy in phase III trials [7], and by the
beginning of January 2021, two messenger RNA (mRNA)
vaccines had been approved by the Swiss Agency for Ther-
apeutic Products (Swissmedic) [9, 10].
The delivery of the COVID-19 vaccines started on 4 Janu-
ary 2021, making it essential to identify and address wide-
spread vaccine uptake barriers. Six months after the start
of the national campaign, almost 50% of the total Swiss
population have received at least one dose of an mRNA
COVID-19 vaccine and about 30% are completely vac-
cinated. Scepticism about these new vaccines against
COVID-19 presents one such challenge to vaccine uptake.
Healthcare workers who face an increased risk of infection
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with SARS-CoV-2 and can transmit the virus among them-
selves and to highly vulnerable patients [11–15] are an
important target group for vaccination. Previous studies
have shown that vaccine uptake for vaccine-preventable
diseases such as influenza is low among healthcare work-
ers [16, 17]. Given the central role they play in treating
COVID-19 and administering vaccinations, healthcare
workers are uniquely positioned to influence vaccine up-
take. Therefore, understanding the willingness of health-
care workers to be vaccinated against COVID-19, mainly
if they are themselves hesitant, will be important in pro-
moting vaccine uptake in the population.
We therefore assessed the willingness of healthcare work-
ers in the Canton of Solothurn, Switzerland, to be vacci-
nated against influenza and COVID-19, and inquired about
reasons for vaccine hesitancy among them.
Methods
Study design
We conducted a cross-sectional web-based survey among
healthcare workers in the Canton of Solothurn, Switzer-
land. We included adults aged 16 years or older who work
in the healthcare system in hospitals, medical practices, re-
tirement and nursing homes, home care, pharmacies and
long-term care facilities.
Data collection
We developed and pilot tested a standardised questionnaire
based on the study of Larson et al. [18] and the Vaccine
Confidence Project at the London School of Hygiene and
Tropical Medicine (www.vaccineconfidence.org/). The
electronic questionnaire collected information of three
types: (i) demographic details such as sex, age, and pro-
fession; (ii) intention to be vaccinated against COVID-19
and reasons for being vaccinated / not being vaccinated or
for being unsure, confidence in government, recommen-
dation of the employer, and additional information need-
ed to take a vaccination decision; (iii) history of influenza
vaccination for the influenza season 2020/21. We collected
the data in mid-December 2020 before the first approval
of a COVID-19 vaccine and associated campaigning, using
a web-based tool (www.findmind.ch). All fields were
mandatory. Free-text fields were restricted to the questions
on reasons for not vaccinating, vaccinating or being unsure
to vaccinate (“other reasons”; the questionnaire is in the
supplementary table S1 in the appendix).
All employees of the cantonal hospital in the Canton of
Solothurn were invited to participate. The survey was also
sent to the cantonal professional associations of physi-
cians, nursing homes, long-term care facilities and residen-
tial care, which invited their members to participate. The
survey was distributed via the commonly used channels of
communication, such as emails, newsletters and weblinks
on the internal hospital website.
Definitions
The Swiss Federal Office of Public Health (FPOH) defined
the following COVID-19 risk groups: persons over the age
of 50; those with comorbidities including hypertension,
chronic respiratory diseases, diabetes, being immunocom-
promised, cardiovascular disease, cancer, or obesity (body
mass index >30 kg/m2); persons who live in a nursing
home or long-term care facility; and those who are preg-
nant.
The survey participants fell into three groups: persons will-
ing to be vaccinated, those who were not willing to be vac-
cinated, and those who were hesitant or unsure about being
vaccinated. Among those willing to be vaccinated against
COVID-19, the reasons for deciding to do so could be
characterised as self-protection, individual vaccination as a
contribution to pandemic control, and belonging to a risk
group for severe COVID-19 disease. Reasons for vaccine
hesitancy included opposition to vaccines in general, the
perception that COVID-19 is harmless or that PPE is suf-
ficient, concerns about the effectiveness of the vaccine, its
safety and side effects, bad experiences with previous vac-
cinations, fear of needles, and other reasons. People who
were unsure about being vaccinated against COVID-19
were hesitant because of perceived inconsistent informa-
tion, doubt about vaccine effectiveness, doubt about vac-
cine safety and fear of side effects, doubt about individual
vaccination for pandemic control, and uncertainty among
colleagues, and lack of information provided by the em-
ployer. Supplementary table S1 provides further details.
Statistical analyses
We used descriptive statistics to characterise the study pop-
ulation by profession and intention to be vaccinated against
COVID-19. Differences between groups were assessed us-
ing chi‐square, t-test or Wilcoxon rank‐sum tests as appro-
priate. We calculated the proportions of people intending
to be vaccinated against COVID-19 with the correspond-
ing 95% confidence intervals (95% CIs).
We examined factors associated with the healthcare work-
ers’ intention to be vaccinated against COVID-19 in uni-
variate and multivariate logistic regression. Logistic mod-
els were adjusted for age group and profession, confidence
in government reports, the employer’s recommendation,
and influenza vaccine uptake 2020/21. We grouped uncer-
tainty about vaccination and having no intention of being
vaccinated against COVID-19. We also performed a sen-
sitivity analysis that combined those who were willing to
be vaccinated and those who were not sure about vaccina-
tion. Finally, we compared the vaccine refusers and those
who were unsure about COVID-19 vaccination. All analy-
ses were performed in Stata (version 15.1, College Station,
TX, USA).
Ethics statement
Data collection was anonymous. No ethical approval was
needed, in line with the Swiss Human Research Act.
Results
A total of 4,244 healthcare workers participated in the sur-
vey. Response rates were as follows: ~64% (2679/~4,200)
among hospital staff, ~38% (338/~900) among medical
practice staff, ~11% (440/~4,000) among nursing home
staff, and ~29% (470/~1,600) among long-term care facili-
ty staff.
We excluded participants who did not fully complete the
survey (n = 421) and those for whom data on sex, age or
profession were missing (n = 12). We further excluded par-
ticipants younger than 16 years (n = 18). The analyses thus
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included 3,793 healthcare workers (see supplementary fig.
S1 in the appendix).
Characteristics of the healthcare workers
The median age of participanting healthcare workers was
43 years (interquartile range [IQR] 31–53), 2,841 were
female (74.9%). Among all healthcare workers, 2,445
(64.5%) worked in hospitals, 398 (10.5%) worked in long-
term care facilities, 373 (9.8%) in retirement and nursing
homes, 311 (8.2%) in medical practices, 232 (6.1%) in
residential care and 34 (0.9%) at pharmacies (table 1 and
supplementary table S2 in the appendix). Asked about
COVID-19 vaccination, 1,511 healthcare workers (39.8%)
reported they planned to have the COVID-19 vaccine,
1,114 (29.4%) said they were unsure and 1,168 (30.8%)
said they would not accept vaccination. Willingness to
be vaccinated was highest among medical doctors, among
whom 467 of 617 (76.1%) were willing to be vaccinated,
and it was lowest among nurses at 470 of 1,690 (27.8%)
(fig.1A and B shows willingness to be vaccinated by pro-
fession and workplace).
The self-reported uptake for seasonal influenza 2020/2021
vaccination was 38.1% (1,446 of 3,793), 118 (3.1%) were
unsure whether they had been vaccinated and 2,229
(58.8%) reported they were not vaccinated. The influenza
vaccination rate was highest among medical doctors
(75.6%) and pharmacists (58.8%). Among the other pro-
Figure 1: Number of people reporting willingness to be vaccinated
against COVID-19 in the Canton of Solothurn, Switzerland by
healthcare profession (A) and by workplace (B). Percent with 95%
confidence intervals are presented.
fessions, the vaccination rate ranged from 11.6% to 44.4%
(table 1).
Determinants of willingness to be vaccinated
The willingness among healthcare workers to be vaccinat-
ed against COVID-19 was lower among females than male
participants (odds ratio [OR] 0.33, 95% Cl 0.28–0.38) and
increased with age. Willingness was highest among the
age group ≥60 years (OR 4.56, 95% Cl 3.50–5.94) com-
pared with the age group <30 years. Healthcare workers
reporting having been vaccinated against seasonal influen-
za 2020/21 were more willing to be vaccinated against
COVID-19 (OR 6.30, 95% Cl 5.45–7.23) than the un-
vaccinated group. Confidence in government reports and
employers’ vaccination recommendation were associated
with willingness to be immunised against COVID-19: OR
4.12 (95% Cl 3.37–5.03) and OR 14.19 (95% Cl
11.53–17.47), respectively. In contrast, lack of such con-
fidence was negatively associated with willingness to get
vaccinated as compared with the group with no opinion
(table 2). The willingness to be vaccinated against
COVID-19 was higher among pharmacists (OR 6.22, 95%
Cl 2.96–13.13) and medical doctors (OR 8.24, 95% Cl
6.66–12.21) than nurses.
In the multivariate analysis, willingness to be vaccinated
was positively associated with confidence in government
reports on the COVID-19 pandemic (adjusted OR [aOR]
1.41, 95% Cl 1.07–1.85) and negatively with lack of con-
fidence in government (aOR 11.40, 95% Cl 8.87–14.65).
Similarly, confidence in employer recommendations was
positively associated, whereas lack of confidence was neg-
atively associated. The analysis confirmed that healthcare
workers who reported vaccination against seasonal in-
fluenza 2020/21 were more likely to be willing to be vac-
cinated against COVID-19 than those who were not vac-
cinated (aOR 2.70, 95% Cl 2.20–3.31, table 2). When an
interaction term with influenza vaccination and age group
was included in the multivariate model, influenza vaccina-
tion and age group were interrelated (p-value from the test
for an interaction p = 0.03).
In the sensitivity analysis grouping the willing and unsure
together (rather than the refusers and unsure), results were
similar to the primary analysis (supplementary table S3).
Reasons for vaccine hesitancy
The main reasons for willingness to be vaccinated were
personal protection, controlling the pandemic and belong-
ing to a risk group (fig. 2A, table 1). These reasons differed
according to profession (p <0.05). The most frequent rea-
sons for vaccine hesitancy among healthcare workers in-
cluded concerns about vaccine safety and side effects
(1,073/1,168, 91.9%), the perception that PPE is sufficient
(328/1,168, 28.1%), and that COVID-19 is harmless (231/
1,168, 19.8%, fig. 2B and table 1). All reasons for vaccine
hesitancy were similar in the different healthcare profes-
sions, except for vaccine safety and side effects, which
were mentioned more frequently as a reason for vaccine
hesitancy by nurses (p = 0.01)
Among the 1,114 healthcare workers who were unsure
about a vaccination decision, 1,055 (94.7%) wanted more
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Table 1:
Characteristics of healthcare workers participating in the survey, overall and by profession.












staff* (n = 380)
Private care-
givers (n = 224)
Staff without pa-
tient contact (n =
788)
Sex
Male 952 (25.1) 202 (12.0) 358 (58.3) 1 (1.6) 10 (29.4) 57 (15.0) 77 (34.4) 247 (31.4)
Female 2,841 (74.9) 1,488 (88.0) 256 (41.7) 62 (98.4) 24 (70.6) 323 (85.0) 147 (65.6) 541 (68.7)
Age in years,
median (IQR)
43 (31–53) 39 (27–52) 46 (36–55) 39 (25–52) 49 (32–59) 43 (30.5–53) 41 (30–55) 48 (36–55)
Workplace
Hospital 2,445 (64.5) 1,122 (66.4) 372 (60.6) 0 0 380 (100) 0 571 (72.5)
Medical practice 311 (8.2) 6 (0.4) 240 (39.1) 58 (92.1) 0 0 0 7 (0.9)
Retirement and
nursing home
373 (9.8) 287 (17.0) 0 2 (3.2) 0 0 0 84 (10.7)
Residential care 323 (6.1) 193 (11.4) 0 2 (3.2) 0 0 0 37 (4.7)
Pharmacy 34 (0.9) 0 0 0 34 (100) 0 0 0
Long-term care
facilities
398 (10.5) 82 (4.9) 2 (0.3) 1 (1.6) 0 0 224 (100) 89 (11.3)
Willingness to get COVID-19 vaccine
Yes 1,511 (39.8) 470 (27.8) 467 (76.1) 24 (38.1) 24 (70.6) 161 (42.4) 68 (30.4) 297 (37.7)
No 1,168 (30.8) 642 (38.0) 55 (9.0) 19 (30.2) 6 (17.6) 93 (24.5) 106 (47.3) 247 (31.3)
Unsure 1,114 (29.4) 578 (34.2) 92 (15.0) 20 (31.8) 4 (11.8) 126 (33.2) 50 (22.3) 244 (31.0)
Opinion on employer’s recommendation




1066 (28.1) 598 (35.4) 75 (12.2) 17 (27.0) 3 (8.8) 86 (22.6) 95 (42.4) 192 (24.4)
Completely and
somewhat agree
1834 (48.4) 640 (37.9) 432 (79.4) 30 (47.6) 23 (67.7) 214 (56.3) 89 (39.7) 406 (51.5)
Opinion on government reports




868 (22.9) 489 (28.9) 48 (7.8) 18 (28.6) 6 (17.7) 57 (15.0) 71 (31.7) 179 (22.7)
Completely and
somewhat agree
2,280 (60.1) 864 (51.1) 519 (84.5) 33 (52.4) 23 (67.7) 268 (70.5) 108 (48.2) 465 (59.0)
Had influenza vaccine 20/21
No 2,229 (58.8) 1,101 (65.2) 113 (18.4) 34 (54.0) 11 (32.4) 217 (57.1) 193 (86.2) 560 (71.1)
Yes 1,446 (38.1) 550 (32.5) 464 (75.6) 28 (44.4) 20 (58.8) 151 (39.7) 26 (11.6) 207 (26.3)





1,511 (100) 470 (100) 467 (100) 24 (100) 24 (100) 161 (100) 68 (100) 297 (100)
Protection 1,461 (96.7) 449 (95.5) 460 (98.5) 23 (95.8) 21 (87.5) 151 (93.8) 65 (95.6) 292 (98.3)
Vaccine for pan-
demic control
1,328 (87.9) 395 (84.0) 434 (92.9) 24 (100) 21 (87.5) 143 (88.8) 55 (80.9) 256 (86.2)





1,168 (100) 642 (100) 55 (100) 19 (100) 6 (100) 93 (100) 106 (100) 247 (100)
Vaccine safety
and side effects
1,073 (91.9) 603 (93.9) 51 (92.7) 17 (89.5) 4 (66.7) 87 (93.5) 90 (84.9) 221 (89.5)
PPE is sufficient 328 (28.1) 193 (30.1) 13 (23.6) 4 (21.1) 1 (16.7) 26 (28.0) 32 (30.2) 59 (23.9)
COVID-19 harm-
less
229 (19.6) 118 (18.4) 20 (36.4) 3 (15.8) 0 16 (17.2) 25 (23.6) 47 (19.0)
Bad experiences 201 (17.2) 111 (17.3) 12 (18.2) 2 (10.5) 0 11 (11.8) 20 (18.9) 45 (18.2)
Effectiveness of
the vaccine




39 (3.3) 20 (3.1) 0 1 (5.3 0 1 (1.1) 5 (4.7) 12 (4.9)
Fear of needles 40 (3.4) 20 (3.1) 1 (1.8) 0 1 (16.7) 4 (4.3) 4 (3.8) 10 (4.0)






1,114 (100) 578 (100) 92 (100) 20 (100) 4 (100) 126 (100) 50 (100) 244 (100)
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Vaccine safety
and side effects
1,058 (95.0) 538 (93.1) 88 (95.7) 18 (90.0) 4 (100) 124 (98.4) 50 (100) 236 (96.7)
Inconsistent infor-
mation
329 (29.5) 192 (33.2) 29 (31.5) 1 (5.0) 1 (25.0) 40 (31.7) 17 (34.0) 51 (20.9)
Effectiveness of
the vaccine
316 (28.4) 177 (30.6) 16 (17.4) 5 (25.0) 1 (25.0) 33 (26.2) 15 (30.0) 69 (28.3)
No education by
my employer
210 (18.9) 126 (21.8) 14 (15.2) 5 (25.0) 0 29 (23.0) 4 (8.0) 32 (13.1)
Uncertainty by my
colleagues
251 (22.5) 147 (25.4) 18 (19.6) 6 (30.0) 0 31 (24.6) 10 (20.0) 39 (16.0)
Vaccine for pan-
demic control




1,114 (100) 578 (100) 92 (100) 20 (100) 4 (100) 126 (100) 50 (100) 244 (100)
Information about
COVID-19
116 (10.4) 68 (11.8) 8 (8.7) 1 (5.0) 0 14 (11.1) 5 (10.0) 20 (8.2)
Information about
the vaccine
1,055 (94.7) 550 (95.2) 81 (88.0) 19 (95.0) 4 (100) 121 (96.0) 47 (94.0) 233 (95.5)
Reports from vac-
cinated people
778 (69.8) 412 (71.3) 45 (48.9) 17 (85.0) 2 (50.0) 74 (58.7) 41 (82.0) 187 (76.6)
Opinion of ex-
perts
404 (36.3) 220 (38.1) 32 (34.8) 9 (45.0) 0 56 (44.4) 15 (30.0) 72 (29.5)
HCW = healthcare workers; IQR = interquartile range; PPE = personal protective equipment
Data are n (%) unless otherwise stated.
* “Other medical staff” includes physical therapists, occupational therapists, speech therapists and midwives.
information on vaccine safety and side effects, 778
(69.6%) awaited reports from already vaccinated people
and 404 (36.3%) wanted an opinion from experts. The
main reasons can be found in figure 2C and table 1. The
reasons for being unsure were similar across the healthcare
professions, but pharmacists more frequently wanted infor-
mation on the vaccine than medical doctors (100% vs 88%,
p = 0.01).
Discussion
Less than half of participating healthcare workers reported
willingness to be vaccinated against COVID-19. The most
frequently given reason for vaccine hesitancy was concern
about vaccine safety and side effects. Nurses were less
likely to be willing to be vaccinated against COVID-19
than medical doctors or pharmacists.
Vaccines are an effective control measure to reduce the
burden of infectious disease. Poliomyelitis was eradicated,
and we are close to eliminating measles, mumps, and
rubella with vaccines [19]. Vaccination will play an im-
portant role in the control of the COVID-19 pandemic.
Even transient herd immunity in Switzerland will require
more than 60% of the population having achieved immuni-
ty to SARS-CoV-2 either through infection and recovery or
through vaccination, particularly when considering the po-
tential impacts of SARS-CoV-2 variants of concern. How-
ever, this proportion varies depending on model assump-
tions [20].
Willingness to get vaccinated is central to achieving herd
immunity. Several cross-sectional studies have assessed
the willingness to get vaccinated. In seven countries, a
European general population survey found that the will-
ingness to be vaccinated against COVID-19 ranged from
62% to 80% [21]. Similar results were found in the United
Kingdom and Ireland, with 69% and 65% acceptance, re-
spectively [22]. In the USA, 37% of healthcare workers re-
ported being willing to get vaccinated against COVID-19
[23]. These results are in line with our results (40%) in the
Canton of Solothurn in Switzerland. These numbers cause
concern because healthcare workers play an important role
in vaccine uptake among the general population. A review
on vaccine hesitancy has shown that vaccinated healthcare
workers are more likely to recommend vaccination than
unvaccinated healthcare workers [24]. Furthermore, a vac-
cination recommendation given by an healthcare worker is
frequently cited as the reason for vaccination acceptance
[25]. In contrast, the lack of such a recommendation was
the most common reason for not being vaccinated [24, 26].
Some healthcare workers have expressed reservations
about the safety and side effects of COVID-19 vaccines.
One contributor to such reservations is the perception of
undue haste in the development of COVID-19 vaccines
compared with previous vaccines. In the twentieth century,
it took a decade or longer to get vaccines to the market,
for example, in the case of poliomyelitis [27]. Many fac-
tors contributed to the comparatively short time it took for
COVID-19 vaccines to be granted emergency use authori-
sations in many countries, with definitive licensing grant-
ed on a rolling basis. Researchers have been developing
mRNA and viral vector-based vaccines for other diseases
for more than a decade [28]. As the pandemic spread, pub-
lic willingness and even demand led to rapid enrolment in
phase I to phase III clinical trials with historically unprece-
dented speed. Simultaneously, the rapid spread of SARS-
CoV-2 allowed endpoint-driven phase III trials to demon-
strate vaccine efficacy sooner than was expected at their
outset.
We found that confidence in the governmental authorities
is associated with willingness to get vaccinated against
COVID-19. During a health crisis or a pandemic, trust in
the government and risk perception play a key role in vac-
cine acceptance [29, 30]. A French survey among general
practitioners showed they were more likely to recommend
vaccines to patients when they trusted official sources of
information [31]. A global survey also reported an associ-
ation between vaccine acceptance and participants’ trust in
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government [32]. High levels of trust in government was
associated with willingness to follow governmental recom-
mendations on preventive behaviours to contain swine flu
[33] or compliance with social distancing measures dur-
ing the Ebola outbreak [34]. In contrast, mistrust and mis-
information reduced compliance with social and behav-
ioural measures [35]. A cross-sectional study during the
COVID-19 pandemic among UK residents showed that
residents who trusted the government to control the pan-
demic were more likely to follow government recommen-
dations during the lockdown [36].
Strategies to increase vaccine coverage among healthcare
workers should draw upon guidance from authorities or
persons conceived as such by a target audience (in this case
healthcare workers) and specific information about vaccine
safety and efficacy. Thus, it is not surprising that many un-
decided healthcare workers want to have reports from fel-
low healthcare workers who have been vaccinated before
they make up their minds. Peers provide important infor-
mation that influences decision making, but this source of
information is often overlooked. Healthcare workers may
be the most effective promotors of vaccination for their fel-
lows.
We observed that healthcare workers who were vaccinated
against seasonal influenza are also more likely to willing to
be vaccinated against COVID-19. Both diseases are con-
tagious respiratory diseases caused by viruses, and they
share some of the same symptoms (fever, cough) and ap-
proaches for prevention (hand hygiene, physical distanc-
ing, and masks). However, there are important differences.
Table 2:
Characteristics of healthcare workers’ willingness to be vaccinated against COVID-19, vaccine hesitancy and uncertainty about vaccination, and factors associated with willing-
ness to be vaccinated.









Total 3,793 1,511 1,168 1,114
Sex
Male 952 561 (58.9) 196 (20.6) 195 (20.5) 1 <0.001
Female 2,841 950 (33.4) 972 (34.2) 919 (32.4) 0.33 (0.28–0.38)
Age groups <0.001 <0.001
29 and younger 829 207 (24.9) 381 (46.0) 241 (29.1) 1 1
30 to 39 807 285 (35.3) 257 (31.9) 265 (32.8) 1.64 (1.33–2.03) 0.93 (0.68–1.25)
40 to 49 790 335 (42.4) 215 (27.2) 240 (30.4) 2.21 (1.79–2.73) 1.29 (0.96–1.76)
50 to 59 1,012 470 (46.4) 254 (25.1) 288 (28.5) 2.61 (2.13–3.18) 1.78 (1.34–2.36)
60 and older 355 214 (60.3) 61 (17.2) 80 (22.5) 4.56 (3.50–5.94) 2.45 (1.68–3.57)
Profession <0.001 <0.001
Medical doctor 614 467 (76.0) 55 (9.0) 92 (15.0) 8.24 (6.66–12.21) 4.88 (3.58–6.65)
Nurse 1,690 470 (27.8) 642 (38.0) 578 (34.2) 1 1




24 16 (66.7) 5 (20.8) 3 (12.5) 6.22 (2.96–13.13) 4.20 (1.53–11.52)
Other medical
staff**
380 161 (42.4) 93 (24.5) 126 (33.2) 1.91 (1.52–2.40) 1.22 (0.89–1.68)
Not close patient
contact
788 297 (37.7) 247 (31.3) 244 (31.9) 1.57 (1.31–1.88) 1.15 (0.89–1.48)
Private caregiver 224 68 (30.4) 106 (47.3) 50 (22.3) 1.13 (0.83–1.53) 1.51 (0.98–2.33)
Confidence in the government reports <0.001 <0.001




868 95 (10.9) 533 (61.4) 240 (27.7) 0.41 (0.31–0.54) 0.58 (0.40–0.84)
Completely and
somewhat agree
2,280 1,266 (55.5) 397 (17.4) 617 (27.1) 4.12 (3.37–5.03) 1.41 (1.07–1.85)
Follow employer’s recommendation <0.001 <0.001




1,066 41 (3.9) 801 (75.1) 224 (21.0) 0.22 (0.15–0.31) 0.30 (0.20–0.44)
Completely and
somewhat agree




Influenza vaccination 20/21 <0.001 <0.001
No 2,347 555 (23.7) 1019 (43.4) 773 (32.9) 1 1
Yes 1,556 956 (66.1) 149 (10.3) 341 (23.6) 6.30 (5.45–7.23) 2.70 (2.20–3.31)
CI = confidence interval; HCW = healthcare worker; OR = odds ratio* Model adjusted for age groups, profession, confidence in the government reports, following employer’s
recommendation, and influenza vaccination 20/21.† “Other medical staff” includes physical therapists, occupational therapists, speech therapists, and midwives
CI = confidence interval; HCW = healthcare worker; OR = odds ratio
* Model adjusted for age groups, profession, confidence in the government reports, following employer’s recommendation, and influenza vaccination 20/21.
** “Other medical staff” includes physical therapists, occupational therapists, speech therapists, and midwives
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Superspreader events are more common for COVID-19
[37], and mortality rates are higher for COVID-19 than for
influenza [38, 39]. A recent study showed that over time,
the uptake of the seasonal influenza vaccine in Switzer-
land had dropped overall, and among older persons (≥65
years) and people with chronic disease [40]. This reduced
coverage might be explained by variable and lower season-
al influenza vaccine effectiveness, which can range from
30–60% [41, 42].
The limitations of this study include different response
rates among the healthcare professions and potential over-
representation of hospital-based healthcare workers. We
conducted a web-based cross-sectional online survey in
which participation was voluntary but highly supported
by the hospital-based personnel. Hospital-based healthcare
workers may be over-represented. Healthcare workers in-
terested in the topic are more likely to respond to the ques-
tionnaire. This might introduce a bias and lead to an over-
or under-estimation of vaccine hesitancy or vaccine ac-
ceptance. The survey was conducted only in the Canton
of Solothurn and the results cannot be necessarily gen-
eralised to the whole of Switzerland. Furthermore, some
cantons were more heavily affected by the pandemic than
others. This may result in different attitudes towards the
COVID-19 vaccine among healthcare workers. Compared
with other online surveys, this survey was distributed
among specific groups of healthcare workers to cover bet-
ter this heterogeneous population. Additionally, attitudes
towards vaccination against COVID-19 and willingness to
get vaccinated change over time. With more people being
vaccinated, acceptance increases, and vaccine hesitancy
might decrease. Finally, the survey was conducted before
the approval of the two COVID-19 vaccines in Switzer-
land. Perceptions of the safety of the vaccine have changed
since the approval of the vaccines and vaccine hesitancy
might have decreased in the months after approval. This is
true for COVID-19 vaccines, but maybe also be true for
any new vaccine introduced in the healthcare sector.
This study’s strength is the inclusion of diverse healthcare
institutions and healthcare workers who play quite dif-
ferent roles within them. We included healthcare workers
working with varying populations of risk ranging from
nursing home residents, hospitalised patients to people liv-
ing in long-term care facilities. Furthermore, the survey
covered the three largest healthcare providers in the canton
of Solothurn.
Conclusions
At this early stage of the COVID-19 vaccine campaign,
the overall willingness to get vaccinated among healthcare
workers is low. Balanced and transparent information on
Figure 2: Reasons for vaccine willingness (A), vaccine hesitancy (B) and being uncertain (C) among all healthcare workers. The exact num-
bers can be found in table 1.
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vaccine efficacy, safety and side effects should be provided
to healthcare workers and dialogue on vaccine hesitancy
initiated.
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Appendix: Supplementary data
Figure S1: Study flow chart.
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Table S1:
Grouping of the reasons for willingness or hesitancy to be vaccinated against COVID-19 or uncertainty about vaccination.
Reasons for willingness to be vaccinated
To protect myself from COVID-19 infection. Protection (myself, patients, and relatives)
Because I want to protect my colleagues at work and my patients.
Because I want to protect my family members (parents, siblings, children, etc.).
Because my vaccination is a contribution to the fight against the pandemic. Vaccine for pandemic control
Because this is the only way to stop the pandemic.
Because I belong to the risk groups. Risk group
Other reasons, please specify Others
Reasons for hesitancy to be vaccinated
I think vaccinations are generally unnecessary. Opponents of vaccination
Vaccination against COVID-19 is not necessary. COVID-19 is harmless
I don't think COVID-19 is dangerous for my health.
COVID-19 is no worse than the flu.
I don't think the vaccine is effective. Effectiveness of the vaccine
I think the COVID-19 vaccine may not be safe.
I am concerned that the vaccine was approved too quickly and has not been tested
enough
Vaccine safety and side effects
I am afraid of possible side effects.
I have had a bad experience or reaction to a previous vaccination Bad experiences with vaccines
I had a bad experience with vaccinations at a previous physician or health clinic.
I am afraid of needles. Fear of needles
I am already protected because I comply with protective measures (masks, hand hy-
giene).
Personal protective equipment is sufficient
I protect my environment because I follow the protective measures, therefore vaccina-
tion is unnecessary.
Because some colleagues do not want to be vaccinated either. Other
Because the experts' opinions are inconsistent
The best way is to let nature take its course.
Religious reasons.
Other reasons, please specify Others
Reasons for being unsure about being vaccinated
The information is inconsistent Inconsistent information
The vaccines were too fast/quickly approved Swissmedic Vaccine safety and side effects
I fear possible side effects.
I don't know if the vaccination will provide protection for me and/or others. Effectiveness of the vaccine
I don't know if my vaccination will help contain the pandemic (herd immunity). Vaccine for pandemic control
My colleagues are also unsure or against vaccination. Uncertainty of my colleagues
I have not yet been educated by my employer. Education by employer
Other Others
Information needed to take a decision
General information about the disease COVID-19. Information about COVID-19
Information on the safety of the vaccination. Information's about vaccine (safety, effectiveness, side effects)
Information about possible side effects of the vaccination.
Information about the effectiveness of the vaccination (does it protect me?)
Information about the vaccination procedure (e.g. how often vaccination is necessary).
Experiences and reports from people who have already been vaccinated. Reported experiences from vaccinated people
A statement from experts Opinion by experts
Other Others
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Table S2:
Participant characteristics by workplace.
Total Hospital Medical practice Nursing home Home care organi-
sation
Pharmacy Long-term care fa-
cilities
Total 3,975 2,445 311 373 232 34 398
Sex
Male 952 (25.1) 576 (23.6 164 (52.7) 59 (15.8) 15 (6.5) 10 (29.4) 128 (6.5)
Female 2,841 (74.9) 1,869 (76.4) 147 (47.3) 314 (84.2) 217 (93.5) 24 (70.6) 270 (67.8)
Age in years, me-
dian (IQR)
43 (31–53) 40 (30–52) 52 (44–60) 46 (30–55) 49.5 (38.5–57) 49 (32–59) 44 (31–55)
Profession
Medical doctor 614 (16.2) 372 (15.2) 240 (77.2) 0 0 0 2 (0.5)
Nurse 1,690 (44.6) 1,122 (45.9) 6 (1.9) 287 (76.9) 193 (83.2) 0 82 (20.6)
Medical assistant 63 (1.7) 0 58 (18.7) 2 (0.5) 2 (0.9) 0 1 (0.3)
Other medical staff* 380 (10.0) 380 (15.5) 0 0 0 0 0
Pharmacist 34 (0.9) 0 0 0 0 24 (70.6) 0
Not close patient
contact
788 (20.8) 571 (23.4) 7 (2.3) 84 (22.5) 37 (16.0) 0 89 (22.4)
Willingness to get COVID-19 vaccine
Yes 1,511 (39.8) 936 (38.3) 226 (72.7) 126 (33.8) 79 (34.0) 24 (70.6) 120 (30.2)
No 1,168 (30.8) 726 (29.7) 32 (10.3) 137 (36.7) 87 (37.5) 6 (17.6) 180 (45.2)
Unsure 1,114 (29.4) 783 (32.0) 53 (17.0) 110 (29.5) 66 (28.5) 4 (11.8) 98 (24.6)
Follow my employer’s recommendation
Completely disagree 443 (11.7) 237 (9.7) 15 (4.8) 64 (17.2) 44 (19.0) 3 (8.8) 80 (20.1)
Somewhat disagree 623 (16.4) 403 (16.5) 32 (10.3) 61 (16.4) 47 (20.3) 0 80 (20.1)
No opinion 893 (23.5) 584 (23.9) 74 (23.8) 101 (27.1) 49 (21.1) 8 (23.5) 77 (19.4)
Somewhat agree 742 (19.6) 528 (21.6) 41 (13.2) 54 (14.5) 43 (18.5) 6 (17.7) 70 (17.6)
Completely agree 1,092 (28.8) 693 (28.3) 149 (47.9) 93 (24.9) 49 (21.1) 17 (50.0) 91 (22.9)
Confidence in the government reports
Completely disagree 230 (6.1) 129 (5.3) 7 (2.3) 37 (9.9) 14 (6.0) 0 43 (10.8)
Somewhat disagree 638 (16.8) 388 (15.9) 33 (10.6) 74 (19.8) 48 (20.7) 6 (17.7) 89 (22.4)
No opinion 645 (17.0) 409 (16.7) 31 (10.0) 76 (20.4) 47 (20.3) 5 (14.7) 77 (19.4)
Somewhat agree 955 (25.2) 645 (26.4) 71 (22.8) 74 (19.8) 70 (30.2) 11 (32.4) 84 (21.1)
Completely agree 1325 (34.9) 874 (35.8) 169 (54.3) 112 (30.0) 53 (22.8) 12 (35.3) 105 (26.4)
Influenza vaccine 20/21
No 2,229 (58.8) 1364 (55.8) 78 (25.1) 262 (70.2) 171 (73.7) 11 (32.4) 343 (86.2)
Yes 1,446 (38.1) 995 (40.7) 222 (71.4) 102 (27.4) 58 (25.0) 20 (58.8) 49 (12.3)
Unsure 118 (3.1) 86 (3.5) 11 (3.5) 9 (2.4) 1 (0.6) 3 (2.4) 6 (1.5)
IQR = interquartile range
Data are n (%) unless otherwise stated.
* “Other medical staff” includes physical therapists, occupational therapists, speech therapists, and midwives.
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Table S3:
Sensitivity analysis: Determinants for the willingness to be vaccinated against COVID-19 (yes/unsure) among healthcare workers compared with healthcare workers with hesi-
tancy.
Variables Total num ber of
participants
Willingness to be vaccinated against
COVID–19: n (%)
Comparison of willingness to be vaccinated against COVID–19 (yes/unsure) with
persons with hesitancy
Yes No Unadjusted OR
(95% Cl)
p–value Adjusted OR (95%
Cl)*
p–value
Total 3,793 2,625 1,168
Sex <0.001
Male 952 756 (79.4) 196 (20.6) 1
Female 2,841 1869 (65.8) 972 (34.2) 0.50 (0.42–0.59)
Age groups <0.001 <0.001
29 and younger 829 448 (54.0) 381 (46.0) 1 1
30 to 39 807 550 (68.2) 257 (31.9) 1.64 (1.33–2.03) 1.48 (1.12–1.97)
40 to 49 790 575 (72.8) 215 (27.2) 2.21 (1.79–2.73) 1.70 (1.23–2.29)
50 to 59 1012 758 (74.9) 254 (25.1) 2.61 (2.13–3.18) 2.08 (1.58–2.73)
60 and older 355 294 (82.8) 61 (17.2) 4.56 (3.50–5.94) 2.72 (1.79–4.13)
Profession <0.001 <0.001
Medical doctor 614 559 (91.0) 55 (9.0) 6.22 (4.64–8.35) 1.93 (1.31–2.84)
Nurse 1,690 1,048 (62.0) 642 (40.0) 1 1
Medical assistant 63 44 (69.4) 19 (30.2) 1.42 (0.82–2.45) 1.20 (0.56–2.57)
Pharmacist and
pharmacist assistant
34 28 (82.4) 6 (17.6) 2.86 (1.18–6.94) 0.85 (0.26–2,79)
Other medical staff† 380 287 (75.5) 93 (24.5) 1.89 (1.47–2.44) 1.04 (0.73–1.47)
No close patient
contact
788 541 (68.6) 246 (31.4) 1.34 (1.12–1.61) 0.62 (0.41–0.94)
Private caregiver 224 118 (52.7) 106 (47.3) 0.68 (0.52–0.90) 0.80 (0.62–1.04)
Confidence in the government reports <0.001 <0.001
No opinion 645 407 (63.1) 238 (36.9) 1 1
Completely and
somewhat disagree
868 335 (38.6) 533 (61.4) 0.37 (0.30–0.45) 0.82 (0.62–1.09)
Completely and
somewhat agree
2,280 1,883 (82.6) 397 (17.4) 2.77 (2.29–3.36) 1.59 (1.23–2.06)
Follow employer’s recommendation <0.001 <0.001
No opinion 893 610 (68.3) 283 (31.7) 1 1
Completely and
somewhat disagree
1,066 265 (24.9) 801 (75.1) 0.15 (0.13–0.19) 0.17 (0.13–0.21)
Completely and
somewhat agree
1,834 1,750 (95.4) 84 (4.6) 9.67 (7.45–12.54) 6.58 (4.94–8.76)
Influenza vaccination 20/21 <0.001 <0.001
No 2,347 1,328 (56.7) 1,019 (43.4) 1 1
Yes 1,556 1,297 (89.7) 149 (10.3) 6.68 (5.53–8.06) 2.48 (1.94–3.17)
CI = confidence interval; OR = odds ratio
* Model adjusted for age groups, profession, confidence in the government reports, following employer's recommendation, and influenza vaccination 20/21.
† “Other medical staff” includes physical therapists, occupational therapists, speech therapists, and midwives.
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